jMedtech and Hydromer forge strategic partnership to build a future-ready global medical device coating platform

This collaboration will create a forward-looking global medical device coating platform. By integrating UV-curable and thermal-curable coating systems, the platform will leverage complementary strengths to provide advanced coating solutions and localized services for global medical device manufacturers.

As a pioneer in China's medical device coating sector, jMedtech has built a dominant position in the domestic market through over a decade of technical accumulation. Its products cover multiple specialized fields including cardiovascular intervention, neurointervention, peripheral vascular intervention, urology, and gastrointestinal applications, with continuously leading market share.

Hydromer brings 46 years of industry heritage as an established U.S. medical device coating company. With complete technological inheritance, extensive clinical validation experience, and advanced cleanroom facilities, it maintains profound influence in the high-end medical device coating market.

jMedtech General Manager Jacqueline Zhang commented on this strategic collaboration, stating that it represents not merely a capital partnership, but a comprehensive integration of technological systems and market resources. By combining our respective strengths in UV-curable and thermal-curable technologies, jMedtech will deliver more comprehensive coating solutions to global customers.

The partners announced plans to establish a mirrored distribution network covering major markets across Asia, the Americas, and Southeast Asia. This strategic layout will significantly enhance supply chain resilience and customer response speed.

This network will provide customers with comprehensive services spanning from R&D support and verification to large-scale production, delivering multiple safeguards for global partners and effectively reducing supply chain risks.

This cooperation provides four significant implications for Chinese medical device companies expanding into the global market:

Chinese companies can now directly access globally leading coating technologies through the mirrored network established by jMedtech and Hydromer. The complementary integration of both companies' UV-curable and thermal-curable technologies enables them to meet diverse client requirements across different international markets.

jMedtech's U.S. production facility can provide Chinese manufacturers with final processing services. This arrangement allows end products to meet "Made in USA" labeling requirements, effectively bypassing tariffs targeting Chinese goods and significantly reducing overall costs.

Hydromer's 46 years of accumulated industry qualifications and compliance expertise streamline the product registration process for partner companies. Its established recognition with the U.S. FDA and other major global regulatory authorities helps clients significantly reduce cumbersome performance validation and material submission requirements, accelerating product time-to-market.

Hydromer's established trust and brand reputation within the U.S. and global high-end medical device sectors serve as a "credit endorsement" for partner companies' product promotion. Its 46-year track record of professional services paves the way for new products to enter premium markets.

The global medical device industry is shifting from single-technology competition to ecosystem competition. The strategic integration between jMedtech and Hydromer pioneers a new model of "technology sharing + production capacity synergy + market complementarity" in the Sino-U.S. medical device segment.